Lv7
4220 积分 2021-03-30 加入
Electrophysiologic and Anatomic Changes in Patients With oHCM on Mavacamten: 1-Year Insights From AI-ECG and Echocardiography Data
1天前
待确认
Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy
1天前
待确认
Multimodality Imaging in the Evaluation of Hypertrophic Cardiomyopathy
1天前
待确认
Rebound Effect in Left Ventricular Structure, Tissue Characteristics, and Function in HOCM After Mavacamten Discontinuation
3天前
已完结
Clinical Outcomes With Mavacamten Use in Patients With Obstructive Hypertrophic Cardiomyopathy Using Real-World Data
3天前
已完结
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion–Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study
5天前
已完结
Luspatercept (RAP-536) modulates oxidative stress without affecting mutation burden in myelodysplastic syndromes
5天前
已完结
Transforming growth factor (TGF)-β pathway as a therapeutic target in lower risk myelodysplastic syndromes
5天前
已完结
Aficamten—A Second in Class Cardiac Myosin Inhibitor for Hypertrophic Cardiomyopathy
6天前
已完结
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
7天前
已完结
皖公网安备34019202002308
